Correspondence 0001104659-23-079189 from Traws Pharma, Inc. (TRAW) (CIK 0001130598) (TRAW)
Traws Pharma, Inc. (TRAW) (CIK 0001130598)
Date: July 7, 2023 · CIK: 0001130598 · Accession: 0001104659-23-079189
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-273081
Letter
Onconova Therapeutics, Inc.
12 Penns Trail
Newtown, PA 18940
July 7, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Lauren Hamill
Re: Onconova Therapeutics, Inc.
Registration Statement on Form S-3
Filed June 30, 2023
File No. 333-273081
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Onconova Therapeutics, Inc. (the “Company”) hereby requests acceleration of the effective date of the above referenced registration statement, as amended, so that such registration statement may become effective at 4:30 p.m. (Washington, D.C. time) on July 11, 2023, or as soon as practicable thereafter.
ONCONOVA THERAPEUTICS, INC.
By: /s/ MARK GUERIN
Name: Mark Guerin
Title: Chief Operating Officer & Chief Financial Officer
Show Raw Text
CORRESP
1
filename1.htm
Onconova Therapeutics, Inc.
12 Penns Trail
Newtown, PA 18940
July 7, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Lauren Hamill
Re: Onconova Therapeutics, Inc.
Registration Statement on Form S-3
Filed June 30, 2023
File No. 333-273081
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended,
Onconova Therapeutics, Inc. (the “Company”) hereby requests acceleration of the effective date of the above referenced registration
statement, as amended, so that such registration statement may become effective at 4:30 p.m. (Washington, D.C. time) on July 11, 2023,
or as soon as practicable thereafter.
ONCONOVA THERAPEUTICS, INC.
By:
/s/ MARK GUERIN
Name:
Mark Guerin
Title:
Chief Operating Officer & Chief Financial
Officer